1. Home
  2. IMNN vs SOS Comparison

IMNN vs SOS Comparison

Compare IMNN & SOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Imunon Inc.

IMNN

Imunon Inc.

HOLD

Current Price

$0.54

Market Cap

5.1M

Sector

Health Care

ML Signal

HOLD

SOS

SOS Limited

SELL

Current Price

$3.57

Market Cap

4.3M

Sector

Finance

ML Signal

SELL

Company Overview

Basic Information
Metric
IMNN
SOS
Founded
1982
2004
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
5.1M
4.3M
IPO Year
2000
2005

Fundamental Metrics

Financial Performance
Metric
IMNN
SOS
Price
$0.54
$3.57
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
★ $15.20
N/A
AVG Volume (30 Days)
133.1K
★ 303.1K
Earning Date
11-12-2026
10-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.50
$0.17
52 Week High
$4.35
$2.08

Technical Indicators

Market Signals
Indicator
IMNN
SOS
Relative Strength Index (RSI) 23.75 96.34
Support Level $0.50 $1.00
Resistance Level $1.28 N/A
Average True Range (ATR) 0.10 0.09
MACD -0.01 0.22
Stochastic Oscillator 9.96 91.12

Price Performance

Historical Comparison
IMNN
SOS

About IMNN Imunon Inc.

Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective and durable responses across a broad array of human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. The first modality, TheraPlas, is developed for the coding of proteins and cytokines in the treatment of solid tumors. The second modality, PlaCCine, is developed for the coding of viral antigens that can elicit an immunological response. The company's clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer.

About SOS SOS Limited

SOS Ltd is a multifaceted company that leverages the power of data to provide marketing solutions, while also participating in the burgeoning fields of blockchain and cryptocurrency operations, as well as commodity trading. Its product offerings are diversified across four main areas: commodity trading, insurance marketing and other Hosting services. The company has single reporting segment: Commodity trading and generates key revenue is generated from Commodity trading.

Share on Social Networks: